See also this year's filing and all EDGAR filings for this company.
PDF Report 0001505512_2019_Regulus_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001505512, Regulus Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 19,295,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 500,000 |
| 2 | PropertyPlantAndEquipmentNet | 7,806,000 |
| 3 | remainder_Assets | 326,000 |
| 4 | LiabilitiesCurrent | 26,646,000 |
| 5 | LiabilitiesNoncurrent | 315,000 |
| 6 | remainder_Liabilities | 6,820,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,686,409 |
| 9 | ResearchAndDevelopmentExpense | -1,452,420 |
| 10 | remainder_Expenses | 2,323,180 |
| 11 | remainder_Revenues | 620,034 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -4,653 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 27,927,000 |
| 1 | Liabilities | 33,781,000 |
| 2 | Expenses | 9,557,169 |
| 3 | Revenues | 620,034 |
| 4 | StockholdersEquity | -5,854,000 |
| 5 | NetIncome | -8,937,135 |
| 6 | ComprehensiveNetIncome | -8,939,462 |
| 7 | BaseVar | 35,944,928 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.703 |
| 9 | EconomicCapitalRatio | 1.36 |